XML 67 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share and Stock Plans (Tables)
 12 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted earnings per share (share data presented in thousands):
 
 Year Ended March 31,
Numerator for basic and diluted earnings per share:202220212020
Net income$29,660 $9,106 $59,672 
Denominators:   
Weighted-average common stock outstanding— denominator for basic EPS28,040 23,897 23,619 
Effect of dilutive employee stock options, RSU's and performance shares361 276 236 
Adjusted weighted-average common stock outstanding and assumed conversions— denominator for diluted EPS28,401 24,173 23,855 
Schedule of Stock Options Roll Forward
A summary of option transactions during each of the three fiscal years in the period ended March 31, 2022 is as follows:
 SharesWeighted-
average
Exercise Price per share		Weighted-
average
Remaining
Contractual
Life (in years)		Aggregate
Intrinsic
Value
Outstanding at April 1, 2019
834,777 23.52 7.04$9,602 
Granted171,515 35.16   
Exercised(296,027)20.26   
Cancelled(183,471)31.01   
Outstanding at March 31, 2020
526,794 26.53 6.93$1,518 
Granted242,178 26.74   
Exercised(97,398)20.24   
Cancelled(13,760)31.85   
Outstanding at March 31, 2021
657,814 27.45 7.29$16,652 
Granted159,643 54.06   
Exercised(105,132)25.24   
Cancelled(32,540)31.71   
Outstanding at March 31, 2022
679,785 33.82 7.08$15,294 
Exercisable at March 31, 2022
322,218 $26.64 5.69$10,190 
Schedule of Share-based Compensation, Stock Options, Activity The following table provides certain information with respect to stock options outstanding at March 31, 2022:
 Stock Options
Outstanding		Weighted-average
Exercise Price		Weighted-average
Remaining
Contractual Life
Range of Exercise Prices   
$10.01 to 20.0071,378 $15.23 3.98
$20.01 to 30.00235,876 $25.17 6.69
$30.01 to $40.00216,117 $34.79 7.09
$40.01 to $50.006,365 $49.36 9.13
$50.01 to $60.00150,049$54.26 9.04
 679,785 $33.82 7.08

The following table provides certain information with respect to stock options exercisable at March 31, 2022:
Range of Exercise PricesStock Options
Exercisable
Weighted- average
Exercise Price per share
$10.01 to 20.0071,378 $15.23 
$20.01 to 30.00138,200 24.93 
$30.01 to $40.00111,122 35.73 
$40.01 to $50.00— — 
$50.01 to $60.001,518 54.26 
 322,218 $26.64 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The following table provides the weighted-average assumptions used to value stock options granted during fiscal 2022, 2021, and 2020:
 
Year Ended
March 31,
2022
Year Ended
March 31,
2021
Year Ended
March 31,
2020
Assumptions:   
Risk-free interest rate0.35 %0.23 %2.23 %
Dividend yield0.44 %0.90 %0.68 %
Volatility factor0.3720.3800.372
Expected life5.5 years5.5 years5.5 years
Schedule of Unvested Restricted Stock Units Roll Forward
A summary of the restricted stock unit awards granted under the Company’s LTIP plan as of March 31, 2022 is as follows:
 SharesWeighted-average
Grant Date
Fair Value per share
Unvested at April 1, 2019
230,197 $30.22 
Granted151,351 38.40 
Vested(106,792)31.90 
Forfeited(62,035)31.61 
Unvested at March 31, 2020
212,721 $35.20 
Granted195,181 29.16 
Vested(125,150)31.85 
Forfeited(12,963)34.74 
Unvested at March 31, 2021
269,789 $32.41 
Granted133,082 49.98 
Vested(138,407)35.71 
Forfeited(19,728)35.41 
Unvested at March 31, 2022
244,736 $39.86 
Schedule of Nonvested Performance-based Units Activity
A summary of the performance shares transactions during each of the three fiscal years in the period ended March 31, 2022 is as follows:
SharesWeighted-average
Grant Date
Fair Value per share
Unvested at April 1, 2019
153,386 $23.11 
Granted38,585 37.67 
Forfeited(125,251)22.67 
Unvested at March 31, 2020
66,720 $32.36 
Granted83,164 25.97 
Vested(23,201)25.28 
Forfeited(3,451)25.28 
Unvested at March 31, 2021
123,232 $29.58 
Granted41,322 52.01 
Vested(18,296)36.43 
Forfeited(8,226)30.25 
Unvested at March 31, 2022
138,032 $35.35